Back

Tau pathology in early Alzheimer's disease disrupts selective neurophysiological network dynamics

Kocagoncu, E.; Quinn, A.; Firouzian, A.; Cooper, E.; Greve, A.; Gunn, R.; Green, G.; Woolrich, M. W.; Henson, R. N.; Lovestone, S.; Deep and Frequent Phenotyping study team, ; Rowe, J. B.

2020-06-12 neuroscience
10.1101/524355 bioRxiv
Show abstract

The role of aggregation of misfolded Tau protein in the pathogenesis of Alzheimers disease is the subject of rapid biomarker development and new therapeutic strategies to slow or prevent dementia. We tested the hypothesis that Tau pathology is associated with functional organization of widespread neurophysiological networks. We used electro-magnetoencephalography (E/MEG) in combination with [18F]AV1451 PET scanning to quantify Tau-dependent network disruption. Using a graph theoretical approach to MEG connectivity, we quantified nodal measures of functional segregation, centrality and efficiency of information transfer. We correlated these metrics against the nodes uptake of [18F]AV1451. There were both regional- and frequency-specific effects of Tau levels on the efficiency of information transfer and network segregation in early AD. Tau correlated with temporal regional participation coefficient (in delta, theta, beta bands); and temporal lobar eigenvector centrality (in theta, alpha, beta bands), but greater eccentricity at higher frequencies (gamma). The results support the translational development of neurophysiological "signatures" as biomarkers of Alzheimers disease, with potential to facilitate experimental medicines studies.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.